Boston Oncology maintains a diverse and extensive portfolio of best-in-class generic and biosimilar therapeutics—USFDA / EMA registered and licensed from world-renowned innovator companies—supporting the entire patient journey.
We are very proud of our reputation for anticipating demand, and growing our portfolio with precision. Our products include the most widely used formulations in critical care, oncology, and pain relief—offering a comprehensive solution to healthcare providers and hospitals.
Leveraging our Global footprint and extensive International experience, Boston Oncology is able to secure licensing agreements for the best formulations in the US and European markets. We deliver products of unparalleled quality by creating modular and highly flexible local manufacturing facilities, sourcing API from the same batches manufactured for the US and European markets; and even pursuing regional approvals using the same files submitted for the original USFDA / EMA registration.
Boston Oncology is aggressively pursuing a research and development program to offer next generation treatments through critical care medicines, specialty generics, oncology products, orphan drugs, and narcotics.
Birato | 250 mg | Tablet
Acalabrutinib BOS | 100 mg | Capsule, Hard
Bortezomib BOS | 3.5 mg | Powder for solution for injection
Busulfan BOS | 60 mg/10 mL | Concentrate for solution for infusion
Xatiza | 60 mg/1.5 mL | Concentrate and solvent for solution for infusion
Emcap | 500 mg | Tablet
Allbloc | 20 mg/20 mL | Concentrate for solution for infusion
Tykodas | 50 mg, 70 mg, 100 mg | Film-coated tablet
Docadex | 20 mg/2 mL, 80 mg/8 mL | Concentrate for solution for infusion
Everolimus BOS | 5 mg, 10 mg | Tablet
Gemcitabine BOS | 1000 mg/30 mL | Concentrate for solution for infusion
Citarox | 100 mg, 200 mg | Powder for solution for infusion
Tecana | 100 mg/5 mL | Concentrate for solution
Lenalidomide BOS | 5 mg, 10 mg, 15 mg, 25 mg | Capsule
Lenvatinib BOS | 4 mg, 10 mg | Capsule
Xorola | 2.5 mg | Film-coated tablet
Batipan | 50 mg, 100 mg | Concentrate for solution for infusion
Pemitax | 500 mg | Powder solution for injection
Sorafenib BOS | 200 mg | Film-coated tablet
Apeto | 15 mg, 100 mg | Powder for solution for injection
Sermitor | 60 mg | Tablet
Demexa | 200 mcg/mL | Solution for injection/infusion
Fomepizole BOS | 1.5 g/1.5 mL | Solution for injection/infusion
Ketorolac BOS | 30 mg/mL | Solution for injection
Milrinone BOS | 10 mg/10 mL | Solution for injection
Rocuronium Bromide BOS | 50 mg/5 mL | Solution for injection
Tranexamic Acid BOS | 1000 mg/10 mL | Solution for injection
Apixaban BOS | 2.5 mg, 5 mg | Film-coated tablet
Bimatoprost BOS | 0.01% | Eye drops, solution
Ferasiro | 90 mg, 180 mg, 360 mg | Film-coated tablet
Levetiracetam BOS | 500 mg/5 mL | Solution for injection
Hemabo | 24 mg/1.2 mL | Solution for injection
Fenido | 267 mg, 801 mg | Film-coated tablet
Teriflunomide BOS | 14 mg | Film-coated tablet
Acidoxax | 4 mg | Concentrate for solution for infusion
Anidulafungin BOS | 100 mg | Powder for concentrate for solution for infusion
Azithromycin BOS | 500 mg | Powder for solution for injection
Copsfin | 50 mg, 70 mg | Powder for concentrate for solution for infusion
Daptomycin BOS | 350 mg | Powder for solution for injection or infusion
Foscarnet BOS | 6000 mg/250 mL | Solution for infusion
Oselow | 75 mg | Capsule
Tigecycline BOS | 50 mg | Powder for infusion
Voriole | 200 mg | Powder for solution
Hulio | 40 mg/0.8 mL | Solution for injection in a pre-filled syringe
Hulio | 40 mg/0.8 mL | Solution for injection in a pre-filled pen
Enoxaparin BOS | 20 mg/0.2 mL, 40 mg/0.4 mL, 60 mg/0.6 mL, 80 mg/0.8 mL | Solution for injection
Nepexto | 50 mg/mL | Solution for injection in a pre-filled pen
Nepexto | 25 mg/0.5 mL, 50 mg/mL | Solution for injection in a pre-filled syringe
Accofil | 300 mcg/0.5 mL, 480 mcg/0.5 mL | Solution for injection/infusion in pre-filled syringe
Pelgraz | 6 mg/0.6 mL | Solution for injection in pre-filled syringe
Tyenne | 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL | Solution for infusion
Tyenne | 162 mg/0.9 mL | Solution for injection in a pre-filled syringe
Tyenne | 162 mg/0.9 mL | Solution for injection in a pre-filled pen
Zercepac | 150 mg | Powder for concentrate for solution for infusion
